Agoracom Blog Home

Archive for the ‘Featured’ Category

Mota Ventures $MOTA.ca Announces Transition After Definitive Close of First Class #CBD Acquisition; Ryan Hoggan is New CEO $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:34 AM on Saturday, February 22nd, 2020
  • Announced a transition after the definitive close of First Class CBD acquisition
  • Appointed Ryan Dean Hoggan to Chief Executive Officer
  • Acquisition of First Class CBD coupled with the upcoming U.S. roll out of the Company’s European CBD brand, Sativida, made the appointment of Mr. Hoggan to Chief Executive Officer a natural fit
  • Mr. Hoggan brings more than 18 years of leadership, global business development and entrepreneurship experience in the health equipment, medical devices and natural health products sectors

VANCOUVER, BC / February 22, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC:PEMTF) (the “Company” or “Mota“) is pleased to announce a transition after the definitive close of First Class CBD acquisition, the Company’s Board of Directors has appointed Ryan Dean Hoggan to Chief Executive Officer. The acquisition of First Class CBD coupled with the upcoming U.S. roll out of the Company’s European CBD brand, Sativida, made the appointment of Mr. Hoggan to Chief Executive Officer a natural fit. Ryan brings a wealth of expertise to this role, being one of the founders of Unified Funding LLC and First Class CBD. Ryan is an experienced strategist, with a strong understanding of building high value consumer brands with significant annual revenue. Ryan’s extensive background in the online e-commerce space will continue to drive the Company’s rapid growth in the US and spearhead its expansion into the European market. The Company intends to continue its roll up strategy of acquiring profitable, well-known CBD brands globally.

Mr. Hoggan brings more than 18 years of leadership, global business development and entrepreneurship experience in the health equipment, medical devices and natural health products sectors. Early in his career, Ryan took on a leadership role in his family business, HOGGAN Health Industries, where he led operations, business development and marketing efforts. After identifying an untapped niche in the market, he founded Hoggan Medical where he went on to launch over 100 health, fitness and medical device products and negotiated contracts with big and small customers including the Mayo Clinic, Boeing, Daimler AG and the Los Angeles Lakers (NBA).

In 2014, Ryan discovered the power of CBD and essential oils – both personally and professionally – after a personal health scare prompted him to research and subsequently try holistic products to improve his health. The experience ultimately led him to become a Partner and President of Offer Space, LLC and Real Oil, LLC, two rapidly growing E-commerce and technology companies focused on serving U.S. based and international consumers in the CBD and natural health products market. In June 2019, Mr. Hoggan led a strategic divestiture of the businesses to Unified Funding, LLC to help continue an impressive growth trend. Through the operations of Unified Funding, LLC, the business has generated a database of over 4.5 million customer records and facilitated over $200 million in consumer transactions from more than one million paying customers in sectors such as beauty, nutrition and CBD products.

Mr. Hoggan holds a Bachelor of Business Administration (BBA) from Westminster College, an MBA from The University of Arizona and a Master of Global Management (MGM) from the Thunderbird School of Global Management at Arizona State University.

In connection with Ryan’s appointment to CEO, Joel Shacker will transition to the role of President of the Company and will remain a member of the board of directors.

“I am very excited to take on the CEO role at Mota and focus the operations on becoming a global E-commerce CBD company. I am also excited about the partnership between Unified and Sativida. Unified’s extensive experience in the U.S. and strong logistics and supply chain will provide significant support for the launch of the Sativida line in the U.S. I believe through the direct-to-consumer online platforms we will become a leader in the CBD space. We plan to aggressively expand First Class’s existing operations in the U.S. as well as launch a European expansion, which we anticipate will yield similar results to our U.S. operations last year,” stated Ryan Hoggan, CEO of the Company.

“We are extremely happy to have someone with Ryan’s extensive experience stepping into this role. I am confident in his ability to execute on expanding operations and generating further revenue. I look forward to continuing to build the Company in my new role as President and to working with Ryan during his transition to CEO of Mota.” stated Joel Shacker.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.
Joel Shacker

President

For further information, readers are encouraged to contact Joel Shacker, President & CEO at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to the Company’s rapid growth in the US and expansion into the European market, its plans to become a vertically integrated global CBD brand, its plans to cultivate and extract cannabis to produce CBD and high-quality value added CBD products in Latin America for distribution domestically and internationally and its plans to acquire revenue-producing CBD brands and operations in Europe and North America. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Mota Ventures Corp.

BEYOND THE DECK: $HPQ.ca Silicon Shares Its PowerPoint Presentation With Investors $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

Posted by AGORACOM-JC at 9:21 AM on Thursday, February 20th, 2020

INTERVIEW: Empower $CBDT.ca Signs Exclusive Content Deal To Further Convert Its’ Database Of 165,000 Patients $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 5:57 PM on Thursday, February 13th, 2020

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Add in the fact patient visits increased 351% in Q4 and it becomes the kind of company small cap investors have been dying to find as they watch pretender companies melt away.

But it doesn’t end there.

CBD extraction has been a key element of the company’s vertical integration. Producing its’ own hemp-derived CBD products for its own massive patient list just makes sense. However, thanks to an LOI (moving towards definitive agreement) to JV with extraction experts Heritage Cannabis, the Company’s 5,000 sq ft facility in Oregon is also planning to serve big brand 3rd party partners in the USA .  Empower brings the infrastructure, Heritage brings the expertise and balance sheet.  The result is a match made in shareholder heaven with initial annual capacity of 6,000 Kg at ~ $US 5,000 per Kg, which adds up to $US 30,000,000 in potential revenue.

But It Doesn’t End There

The Company’s CEO, Steven McAuley is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has brought Empower so far in just 11 months.

If anyone understands digital, it’s McAuley. So it should come as no surprise the Company just signed an exclusive multi-year, multi-national licensing deal with EuroLife to license its “Cannvas.me” cloud based online education platform for the US and Mexico.  Amongst other things, Empower plans to integrate the education platform into its clinics across the United States to help further convert their 165,000 patient database to CBD and medical cannabis through proper education.  

The site also contains premium content for physicians who need to educate themselves and comes with millions of page views already, as well as, 15,000 opted in subscribers, which explains the $460,000 in licensing over 3 years – but $210,000 of that is Empower stock priced at $0.10 (125% above current market prices, which gives you an idea of the confidence EuroLife principals have in the future of Empower.

P.S.  The interview takes place from the floor of the Arizona Cannabis Expo, where Empower has multiple booths and an actual pop-up clinic to acquire new customers in real-time.  That’s what happens when you have a company run by a Six Sigma Certified CEO.

Grab your favourite beverage and settle in to watch what may be your next great small cap investment.

INTERVIEW: $HPQ.ca Game Changing Silicon Process For #Lithium-Ion #Battery Market Is Just Months Away $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

Posted by AGORACOM-JC at 5:59 PM on Tuesday, February 11th, 2020

When a globally renowned technology partner – who supplies plasma torch technology to US Aircraft Carriers – says the following about your company, you are forced to stand up and take notice:

“We never thought, when we first embarked on this project, that we would be developing game-changing technology sought after by the Lithium-ion battery market.”

– Peter Pascali, President and CEO of PyroGenesis Canada Inc. 

There is no shortage of small cap companies claiming they want to supply materials to the Lithium-Ion battery market …. but only one of them is pursuing the material that can increase capacity by as much as 10X ….. Silicon. 

HPQ Silicon (HPQ:TSXV) isn’t just pursuing Silicon, they are on the verge of providing the market with multiple high-value silicon products sought after by Corporations building the next generation of Lithium-ion batteries, including one undisclosed company that is already under NDA with HPQ Silicon.

One of the best parts?  HPQ Silicon doesn’t have to worry about capital expenditure barriers that come with mining battery metals …. because Silicon is manufactured and HPQ has a patent pending process to manufacture Silicon at some of the lowest prices in the world.  A process that is fully funded all the way through to their pilot plant launching this year. 

If you believe in a future driven by electric vehicles and renewable energy, grab your favourite beverage and watch this video interview with CEO Bernard Tourillon.

Developing New #PUREVAP™ Silicon Metal Nano Reactor for Low-Cost Manufacturing of Spherical Silicon Metal Nanopowders & Nanowires for Next Generation Li-ion Batteries $HPQ.ca $PYR.ca $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

Posted by AGORACOM-JC at 8:40 AM on Tuesday, February 11th, 2020
  • After the successful GEN2 PUREVAPTM QRR proof of concept test, PyroGenesis finalised the engineering designs and the plans required to upgrade a PUREVAPTM QRR into a PUREVAPTM reactor that can transform melted silicon metal into spherical Nano-Powders and Nanowires
  • As a result of this work, a new provisional patent application was filed to protect this new process.

MONTREAL, Feb. 11, 2020 — HPQ Silicon Resources Inc. (“HPQ” or the “Company”)TSX-V: HPQ; FWB: UGE; Other OTC : URAGF; (“HPQ”) would like to update shareholders on the steps being undertaken by HPQ and PyroGenesis Canada Inc. (TSX-V: PYR) (“PyroGenesis”) to advance the development of a new low cost manufacturing process that can produce the Spherical Silicon Metal (Si) Nano-Powders and Si Nanowires needed for the next generation of Lithium-ion (Li-ion) Si batteries.

BUILT ON 5 YEARS OF PUREVAPTM QUARTZ REDUCTION REACTOR (QRR) DEVELOPMENT KNOW-HOW

After the successful GEN2 PUREVAPTM QRR proof of concept test, PyroGenesis finalised the engineering designs and the plans required to upgrade a PUREVAPTM QRR into a PUREVAPTM reactor that can transform melted silicon metal into spherical Nano-Powders and Nanowires.  As a result of this work, a new provisional patent application was filed to protect this new process.

DEVELOPING THE PUREVAPTM SILICON METAL NANO REACTOR (SiNR)

The new PUREVAPTM process is a Silicon Metal Nano Reactor, (PUREVAPTM SiNR), that incorporates the PUREVAPTM QRR (patent pending) unique capability of removing impurities from Silicon Metal (Si) into a novel proprietary process that allows different purities of Si feed stock to be melted into liquid Si.  This liquid Si can then be synthesized into the Spherical Silicon Metal Nano Powders and Nanowires sought after by Corporations looking into building the next generation of Lithium-ion batteries.

“The PUREVAPTM SiNR opens up a unique multibillion-dollar business opportunity for HPQ and PyroGenesis.  PyroGenesis has a long track record of taking high-tech industrial projects from proof of concept to global commercial scalability, so we are very confident about the prospect of being one of the first companies coming to market with a low cost process that makes the spherical Silicon Metal Nano-Powders and Nanowires that next generation Li-ion battery manufacturers are seeking,” said Bernard Tourillon, President and CEO HPQ Silicon. “Silicon Metal’s potential to meet energy storage demand is undeniable and generating massive investments, as well as, serious industry interest, so our timing could not be better.”

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c7487bc7-213f-426f-91e2-21737733f9e0

GEN2 PUREVAPTM QRR CONVERTED INTO A PROOF OF COMMERCIAL SCALABILITY PUREVAPTM SINR

The quickest way to demonstrate the capabilities of the PUREVAPTM SiNR process is to upgrade the existing GEN2 PUREVAPTM QRR into PUREVAPTM SiNR test bed, run a series of tests to confirm the scalability, the low-cost nature of the process and its feedstock flexibility.  During these tests, Spherical Silicon Metal Nano-Powders and Nanowires samples will be produced and sent to either research centers for independent valuation or made available to potential end users looking at manufacturing next generation Li-ion batteries.  Successful tests will demonstrate the process flexibility in making a range of advanced Silicon Metal materials.  The preliminary timeline is for the reactor conversion to be completed over the next coming months, with a goal of being able to have samples ready in this fiscal year.

SPHERICAL Si NANO POWDERS AND NANOWIRES KEY TO HIGHER ENERGY DENSITY LI-ION BATTERIES

Spherical Silicon Metal Nano-Powders and Si Nanowires have been identified as key elements that will allow the manufacture of high-performance Li-ion batteries using Silicon Metal (Si) anodes needed to deliver on the research promises of an almost tenfold (10x) increase in the specific capacity of the anode, inducing a 20-40% gain in the energy density of Li-ion batteries.  Current manufacturing methods for Silicon Metal Nano-Powders are expensive, not very scalable and not commercially feasible with US$ 30,000/kg1 selling prices, while manufacturing Silicon Metal Nanowires is so prohibitive that only government funded special projects can afford them. 

“The opportunities that are being developed with the PUREVAP™ process is nothing short of intoxicating,” said M. P Peter Pascali, President and CEO of PyroGenesis Canada Inc. “We never thought, when we first embarked on this project, that we would be developing game-changing technology sought after by the Lithium-ion battery market. We are looking forward to successfully incorporating and upgrading the PUREVAP QRR™ into the PUREVAP™ Nano reactor to produce Spherical Silicon Metal (Si) Nano-Powders and Si Nanowires needed for the next generation of Lithium-ion (Li-ion) Si batteries.”

About Silicon Metal

Silicon Metal (Si) is one of today’s strategic materials needed to fulfil the renewable energy revolution presently under way. Silicon does not exist in its pure state; it must be extracted from quartz, one of the most abundant minerals of the earth’s crust and other expensive raw materials in a carbothermic process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is developing, with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma base processes, the innovative PUREVAPTM “Quartz Reduction Reactors” (QRR), a truly 2.0 Carbothermic process (patent pending), which will permit the One Step transformation of Quartz (SiO2) into High Purity Silicon (Si) at prices that will propagate its considerable renewable energy potential.  The Gen3 PUREVAPTM QRR pilot plant that will validate the commercial potential of the process is scheduled to start during Q1 2020.

HPQ, working with PyroGenesis, is also developing the PUREVAPTM Silicon Metal Nano Reactor (SiNR), a proprietary process a that can use as feedstock different purities of Silicon Metal (SI), melted them into liquid Si that can then be synthesized into the Spherical Silicon Metal Nano Powders and Nanowires necessary for the next generation of Lithium-ion batteries.  During H1 2020, the plan is to validate our game changing manufacturing approach by upgrading our existing Gen2 PUREVAPTM QRR reactor into a PUREVAPTM SINR to produce spherical Silicon Metal (Si) nano-powders and nanowires samples for industry participants and research institutions’.

Concurrently, HPQ is also working with industry leader Apollon Solar to develop a manufacturing capability that uses the High Purity Silicon (Si) made with the PUREVAP™ to make Porous silicon wafers needed for solid-state Li-ion batteries.  The first Silicon wafer should be ready to be ship for testing to a battery manufacturer (under NDA) during H1 2020.

Finally, with Apollon Solar, we are also looking into developing a metallurgical pathway of producing Solar Grade Silicon Metal (SoG Si) that will take full advantage of the PUREVAPTM QRR one-step production of Silicon (Si) material of 4N+ purity with low boron count (< 1 ppm).

The focus of HPQ focus is to become the lowest cost producer of Silicon Metal (Si), High Purity Silicon Metal (Si), Spherical Si nano-powders for Next Gen Li-ion batteries, Porous Silicon Wafers for Solid states Li-ion batteries, Porous Silicon Powders for Li-ion batteries and Solar Grade Silicon Metal (SoG-Si).

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders. 

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact
Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

Empower Clinics $CBDT.ca Announces Strong Start to The Year with January 2020 Patient Visits Increasing by 188% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 6:31 AM on Tuesday, February 11th, 2020
  • Announced that patient visits in corporate clinics increased by 188% in January 2020 versus the same period in 2019, with total patient visits of 1,750 in January 2020 compared to 607 in January 2019.

VANCOUVER, BC /February 11, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(OTC:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company is pleased to announce that patient visits in corporate clinics increased by 188% in January 2020 versus the same period in 2019, with total patient visits of 1,750 in January 2020 compared to 607 in January 2019.

“January patient volumes were strong, setting the stage for potentially record first quarter patient visits, that are always focused on the patient experience, it’s a competitive advantage and I continue to be impressed with how our team members care for each and every patient they see.” said Steven McAuley, Chairman & CEO of Empower. “Looking forward, we are excited for our next franchise signings and the expansion of our product lines, adding to the in-clinic retail experience we are building.”

The Company utilizes it’s technology platform to communicate with patients by text message, email and call center ensuring appointments are confirmed and expected patient visits take place as planned.

The Company’s Sun Valley Health division also completed the set up and build out of it’s retail product counter and sales areas in it’s Tucson, AZ location, to showcase it’s CBD product line with over 50 unique SKU’s. Patients and customers can purchase product in clinic locations or online at www.sunvalleyhealth.com.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

CEO

[email protected]

604-789-2146

Investors: Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

CLIENT FEATURE: Sean Ryan Looking to Repeat Discovery Process with LabGold’s $LAB.ca Hopedale Project $RIO.ca $WHM.ca $SIC.ca $NXS.ca

Posted by AGORACOM at 1:16 PM on Friday, February 7th, 2020
This image has an empty alt attribute; its file name is LAB-square-logo-2.png

SPONSOR: Labrador Gold – Two successful gold explorers lead the way in the Labrador gold rush targeting the under-explored gold potential of the province. Exploration has already outlined district scale gold on two projects, including a 40km strike length of the Florence Lake greenstone belt, one of two greenstone belts covered by the Hopedale Project. Click Here for More Info

Labrador Gold: District Scale Discovery Potential

  • First stage drilling on selected targets in 2020 at Hopedale
  • Large under-explored properties, including the major portion of two greenstone belts
  • Potential for discovery of new gold district(s)
  • Experienced exploration success in finding gold deposits (>17 million oz)
  • First mover advantage
  • Results of aggressive initial exploration programs already indicate district scale gold targets

Hopedale Project Highlights:

  • Discovered a new gold showing north of the Thurber Dog gold occurrence, grab samples from which assayed between 1.67 and 8.26 g/t Au.
  • The Thurber Dog gold occurrence has assays in grab and channel samples from below detection up to 7.866 g/t Au, with 5 samples greater than 1 g/t Au and 16 samples assaying greater than 0.1 g/t Au.
  • The discovery extends the potential strike length of gold mineralization by approximately 500 metres along strike to the north.
  • The new showing occurs within a larger 3km trend of anomalous gold in rock and soil associated with the contact between mafic/ultramafic volcanic rocks and felsic volcanic rocks.

Exploration at Hopedale during 2020 will focus on determining the extent of the Thurber Dog mineralized trend. Such work would aim to fill in the gaps between showings over the three-kilometre strike length with sampling and VLF-EM surveys. LabGold also intends to carry out an initial drill program targeting prospective areas along this trend, including the new showing.

 The Hopedale property covers much of the Hunt River and Florence Lake greenstone belts that stretch over 80 km. The belts are typical of greenstone belts around the world but have been underexplored by comparison. Initial work by Labrador Gold during 2017 show gold anomalies in soils and lake sediments over a 3 kilometre section of the northern portion of the Florence Lake greenstone belt in the vicinity of the known Thurber Dog gold showing where grab samples assayed up to 7.8g/t gold. In addition, anomalous gold in soil and lake sediment samples occur over approximately 40 kilometres along the southern section of the greenstone belt (see news release dated January 25th 2018 for more details). Labrador Gold now controls approximately 57km strike length of the Florence Lake Greenstone Belt.

FULL DISCLOSURE: Labrador Gold is an advertising client of AGORA Internet Relations Corp.

Esports Entertainment Group Completes Reverse Stock Split in Connection with Application for Uplisting To NASDAQ Capital Market $GBML #Esports $TECHF $ATVI $TTWO $GAME $EPY.ca $FDM.ca $TNA.ca

Posted by AGORACOM at 8:27 AM on Thursday, February 6th, 2020
  • Common stock began trading on a post-split basis on Monday, January 27, 2020 under the trading symbol “GMBLD.”
  • The “D” lettering will be removed within 20 business days from the effective date of the reverse split, and the symbol will revert to the original lettering of “GMBL

Birkirkara, Malta–(February 6, 2020) – Esports Entertainment Group, Inc. (OTCQB: GMBLD) (or the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, has successfully completed a “reverse split” of its shares of common stock at a ratio of 1-for-15 (1:15). The Company’s common stock began trading on a post-split basis on Monday, January 27, 2020 under the trading symbol “GMBLD.” The “D” lettering will be removed within 20 business days from the effective date of the reverse split, and the symbol will revert to the original lettering of “GMBL.” In connection with the reverse stock split, the Company’s CUSIP number will change to 29667K306.

The reverse stock split was implemented by the Company in connection with its proposed application to uplist the Company’s common stock on the NASDAQ Capital Market (NASDAQ). The reverse stock split is an action intended to fulfill the stock price requirements for official listing on NASDAQ, which requires that the Company’s common stock must be $4.00 or higher at the time of listing. There can be no assurance that the Company will satisfy other applicable requirements for listing its common stock on NASDAQ or that the Company’s application to uplist its common stock will be approved.

“This reverse split is another major step forward in our long-term strategic growth plan, which includes listing our common stock on a major U.S. exchange,” said CEO Grant Johnson. “We expect a NASDAQ listing will generate even greater interest in our company from the broader national and international investment community, as well as, potential partners in the esports as a result of our transparency. We appreciate the continued support of our employees, partners, and shareholders as we work to realize our operational and capital markets goals.”

As a result of the 1:15 reverse stock split, every 15 shares of the Company’s issued and outstanding common stock will be converted into one share of issued and outstanding common stock. The number of authorized shares will remain unchanged.

No fractional shares will be issued in connection with the stock split. Any fractional shares of common stock resulting from the reverse stock split will be rounded up to the nearest whole share. It is not necessary for stockholders to exchange their existing stock certificates for new stock certificates in connection with the reverse stock split. Stockholders who hold their shares in brokerage accounts are not required to take any action to exchange their shares.

This press release is available on our Online Investor Relations Community for shareholders and potential shareholders to ask questions, receive answers and collaborate with management in a fully moderated forum https://agoracom.com/ir/EsportsEntertainmentGroup

RedChip investor relations Esports Entertainment Group Investor Page:
http://www.gmblinfo.com

ABOUT ESPORTS ENTERTAINMENT GROUP

Esports Entertainment Group, Inc. is a licensed online gambling company with a focus on esports wagering and 18+ gaming. Esports Entertainment offers bet exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The Company maintains offices in Malta. Esports Entertainment common stock is listed on the OTCQB under the symbol GMBLD, which will revert back to GMBL after 20 business days from the effective date of the reverse split announced in this press release. For more information visit www.esportsentertainmentgroup.com

Contact:

Corporate Finance
+356-2757-7000 (Malta)
[email protected]

Media & Investor Relations Inquiries
AGORACOM
[email protected]
http://agoracom.com/ir/eSportsEntertainmentGroup

U.S. Investor Relations
RedChip
Dave Gentry
407-491-4498
[email protected]

INTERVIEW: $HPQ.ca Porous Silicon Attracts Lithium-Ion Battery Manufacturer $FSLR $SPWR $CSIQ $PYR.ca $XMG.ca

Posted by AGORACOM-JC at 4:00 PM on Thursday, January 30th, 2020

North Bud Farms $NBUD.ca Announces Proposed Terms for the Second Tranche of its Non-Brokered Private Placement and Provides a Corporate Update $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:11 PM on Monday, January 27th, 2020
  • First tranche of the Offering closed on November 6, 2019, at which time the Company issued an aggregate of 1,264 Units for gross proceeds of $1,264,000
  • Accordingly, the Company can issue up to an additional $2,736,000 of Units under the Second Tranche
  • In the context of a regular follow-up communication with Health Canada, representatives of the Company received verbal feedback that the application review is complete and the reviewers do not have any more questions.

TORONTO, Jan. 27, 2020 – North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce that it is arranging a closing for the second tranche (the “Second Tranche“) of its non-brokered private placement of 10% secured convertible debenture units (the “Units“) of the Company at a price of C$1,000 for gross proceeds of up to C$4,000,000, originally announced on November 6, 2019 (the “Offering“). The first tranche of the Offering closed on November 6, 2019, at which time the Company issued an aggregate of 1,264 Units for gross proceeds of $1,264,000. Accordingly, the Company can issue up to an additional $2,736,000 of Units under the Second Tranche.

Each Unit issued in connection with the Second Tranche of the Offering is comprised of one C$1,000 principal amount of secured convertible debenture (a “Convertible Debenture“) accruing interest at 10.0% per annum, payable semi-annually in arrears until maturity, and 5,556 common share purchase warrants of the Company (each, a “Warrant“). The Convertible Debentures will have a maturity date of 36 months from the date of issuance. In addition, under the Second Tranche, the Company has the right to prepay an amount equal to the 1st year of interest to be earned by issuing common shares at a deemed price of $0.25 per common share (the “Prepaid Interest Shares”) on the 15th day following the Closing Date should the holders of the Convertible Debentures not elect to receive their 1st year interest paid in cash.

Each Convertible Debenture shall be convertible into common shares in the capital of the Company (each, a “Conversion Share“) at a price of $0.18 (the “Conversion Price“) per Conversion Share.

Each Warrant entitles the holder thereof to acquire one common share in the capital of the Company (each, a “Warrant Share“) for an exercise price of $0.30 per Warrant Share for a period of 36 months following the closing date.

The Convertible Debentures are direct secured obligations of the Company and rank pari passu in right of payment of principal and interest with all other Convertible Debentures issued under the Offering.

Certain directors of the Company have indicated that they may participate in the private placement. Any such purchase would constitute a “related party transaction” within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The proposed issuance to directors of the Company would be exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of any Units issued to or the consideration paid by such insiders would not exceed 25% of the Company’s market capitalization.

The Company may pay registered dealers (the “Finders“) a cash commission equal to up to 8% of the aggregate gross proceeds from the sale of the Units sold pursuant to the Offering to eligible investors introduced to the Company by such Finders. In addition, the Company will grant warrants (the “Compensation Warrants”) exercisable at the Conversion Price for a period of 24 months from the Closing Date to acquire in aggregate the number of Common Shares equal to 8% of the gross proceeds under the Offering divided by the Conversion Price.

The proceeds of the Second Tranche will be used by the Company for expansion of the Company’s facilities and for general corporate and working capital purposes.

The Convertible Debentures, Warrants, Prepaid Interest Shares (if any), and any Compensation Warrants issued pursuant to the Second Tranche of the Offering and any common shares in the capital of the Company issued on conversion of the Convertible Debentures or exercise of the Warrants or Compensation Warrants will be subject to a statutory hold period in Canada of four months and one day following the closing date in accordance with applicable securities laws. Additional resale restrictions may be applicable under the laws of other jurisdictions, if any.

The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“) or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Amendment to Securities Issued in First Tranche of the Offering

The Company further announces that, in order to ensure equitable treatment of holders, it has decided to amend the terms of the debentures (the “First Tranche Debentures“) and warrants (the “First Tranche Warrants“) issued under the first tranche of the Offering, which closed on November 6, 2019. The Company has amended the First Tranche Debentures to reduce the conversion price to $0.18 per common share and has amended the terms of the First Tranche Warrants to: (a) increase the number of warrants issued per $1000 of principal amount of debenture from 2,000 to 5,556; (b) increase the exercise price from $0.25 to $0.30 per warrant; and (c) extend the expiry date of the warrants from 18 months following the closing date to 36 months following the closing date. The amendments are subject to the final approval of the Canadian Securities Exchange (CSE).

Corporate Update

The Company would also like to provide an update regarding the status of its standard cultivation licence application with Health Canada under the Cannabis Act. In the context of a regular follow-up communication with Health Canada, representatives of the Company received verbal feedback that the application review is complete and the reviewers do not have any more questions. Subject to the re-submission of a required foreign police certificate related to one of the foreign directors of the Company, the Company will be in the final queue for receiving its licence. The Company is confident that it will be able to file the certificate promptly; however, there can be no assurance as to the exact timing of the issuance of the licence by Health Canada or whether the Company will receive any final request from Health Canada.

Further to the Company’s announcement regarding its acquisition of certain California-based businesses on November 22, 2019, the Company has proceeded with the issuance of 1,716,000 common shares, at an issue price of $0.25 per share, to an arm’s length advisor to the Company. The shares, which are subject to a statutory hold period as required by applicable securities laws, are based upon the $429,000 cash value of the 3% M&A fee payable to such advisor in respect of the foregoing California acquisitions.

About North Bud Farms Inc.
North Bud Farms Inc., through its U.S. subsidiary Bonfire Brands USA, has acquired cannabis production facilities in California and in Nevada. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada property is located on 3.2-acres of land which was acquired through the acquisition of Nevada Botanical Science, Inc. a world class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation which holds medical and adult use licenses for cultivation, extraction and distribution. Through its wholly owned Canadian subsidiary, GrowPros MMP Inc., the company is pursuing a licence under The Cannabis Act, to cultivate in its state-of-the-art purpose-built cannabis production facility located on 135-acres of Agricultural Land in Low, Quebec, Canada.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE“) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements that include, but are not limited to, statements related to the intended use of proceeds from the Offering, and the status of the Company’s licence application with Health Canada under the Cannabis Act. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms Inc.’s final long form prospectus dated August 21, 2018, which is available under the issuer’s SEDAR profile at www.sedar.com. 

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]